It is still not for the old iron: Adjuvant effects of carbonyl iron in experimental autoimmune encephalomyelitis induction

Journal of Neurochemistry

Volumn 118, Issue 2, 2011, Pages 205-214

  Miljković, Djordje ^a   Momčilović, Miljana ^a   Stanojević, Željka ^a   Rašić, Dejan ^b   Mostarica Stojković, Marija ^a  

^a UNIVERSITY OF BELGRADE   (Serbia)

^b CLINICAL CENTER OF SERBIA   (Serbia)

Author keywords

experimental autoimmune encephalomyelitis; gra nulocytes; multiple sclerosis; nitric oxide; NK cells; T cells

Indexed keywords

3 NITROTYROSINE; CARBONYL IRON; FREUND ADJUVANT; INDUCIBLE NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE; PEROXYNITRITE;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CD4+ T LYMPHOCYTE; CELL INFILTRATION; CELLULAR IMMUNITY; CONTROLLED STUDY; FEMALE; GRANULOCYTE; HOMOGENATE; IMMUNIZATION; MULTIPLE SCLEROSIS; NATURAL KILLER CELL; NATURAL KILLER T CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT;

ANIMALS; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; FEMALE; FREUND'S ADJUVANT; IRON CARBONYL COMPOUNDS; IRON COMPOUNDS; RATS; SEVERITY OF ILLNESS INDEX;

AGOUTI; ANIMALIA; RATTUS;

EID: 79959998992     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2011.07303.x     Document Type: Article

References (43)

1. Aboul-Enein F., Weiser P., Höftberger R., Lassmann H., and, Bradl M., (2006) Transient axonal injury in the absence of demyelination: a correlate of clinical disease in acute experimental autoimmune encephalomyelitis. Acta Neuropathol. 111, 539-547. (Pubitemid 43778958)
2. Ahn M., Kang J., Lee Y., Riu K., Kim Y., Jee Y., Matsumoto Y., and, Shin T., (2001) Pertussis toxin-induced hyperacute autoimmune encephalomyelitis in Lewis rats is correlated with increased expression of inducible nitric oxide synthase and tumor necrosis factor alpha. Neurosci. Lett. 308, 41-44. (Pubitemid 32607676)
3. Archer H., and, Wall R., (2003) Acute haemorrhagic leukoencephalopathy: two case reports and review of the literature. J. Infect. 46, 133-137. (Pubitemid 36221661)
4. Batoulis H., Addicks K., and, Kuerten S., (2010) Emerging concepts in autoimmune encephalomyelitis beyond the CD4/T(H)1 paradigm. Ann. Anat. 192, 179-193.
5. Baxter A. G., (2007) The origin and application of experimental autoimmune encephalomyelitis. Nat. Rev. Immunol. 7, 904-912. (Pubitemid 350006239)
6. Bielekova B., Catalfamo M., Reichert-Scrivner S., Packer A., Cerna M., Waldmann T. A., McFarland H., Henkart P. A., and, Martin R., (2006) Regulatory CD56(bright) natural killer cells mediate immunomodulatory effects of IL-2Rα-targeted therapy (daclizumab) in multiple sclerosis. Proc. Natl Acad. Sci. USA 103, 5941-5946.
7. Calabrese V., Scapagnini G., Ravagna A., Bella R., Foresti R., Bates T. E., Giuffrida Stella A. M., and, Pennisi G., (2002) Nitric oxide synthase is present in the cerebrospinal fluid of patients with active multiple sclerosis and is associated with increases in cerebrospinal fluid protein nitrotyrosine and S-nitrosothiols and with changes in glutathione levels. J. Neurosci. Res. 70, 580-587. (Pubitemid 35253528)
8. Capello E., and, Mancardi G. L., (2004) Marburg type and BalÁ's concentric sclerosis: rare and acute variants of multiple sclerosis. Neurol. Sci. 25(Suppl 4S), 361-363.
9. Cifone M. G., D'AlÁ S., Parroni R., Millimaggi D., Biordi L., Martinotti S., and, Santoni A., (1999) Interleukin-2-activated rat natural killer cells express inducible nitric oxide synthase that contributes to cytotoxic function and interferon-gamma production. Blood 93, 3876-3884. (Pubitemid 29249836)
10. Cross A. H., Manning P. T., Stern M. K., and, Misko T. P., (1997) Evidence for the production of peroxynitrite in inflammatory CNS demyelination. J. Neuroimmunol. 80, 121-130. (Pubitemid 28015331)
11. El-behi M., Rostami A., and, Ciric B., (2010) Current views on the roles of Th1 and Th17 cells in experimental autoimmune encephalomyelitis. J. Neuroimmune Pharmacol. 5, 189-197.
12. Farias A. S., de la Hoz C., Castro F. R., Oliveira E. C., Ribeiro dos Reis J. R., Silva J. S., Langone F., and, Santos L. M., (2007) Nitric oxide and TNFalpha effects in experimental autoimmune encephalomyelitis demyelination. Neuroimmunomodulation 14, 32-38. (Pubitemid 47340633)
13. Hao J., Liu R., Piao W., Zhou Q., Vollmer T. L., Campagnolo D. I., Xiang R., La Cava A., Van Kaer L., and, Shi F. D., (2010) Central nervous system (CNS)-resident natural killer cells suppress Th17 responses and CNS autoimmune pathology. J. Exp. Med. 207, 1907-1921.
14. Hart M. N., and, Earle K. M., (1975) Haemorrhagic and perivenous encephalitis: a clinical-pathological review of 38 cases. J. Neurol. Neurosurg. Psychiatry 38, 585-591.
15. Hu W., and, Lucchinetti C. F., (2009) The pathological spectrum of CNS inflammatory demyelinating, acute primary progressive forms of diseases. Semin. Immunopathol. 31, 439-453.
16. Infante-Duarte C., Weber A., Kratzschmar J., et al. (2005) Frequency of blood CX3CR1-positive natural killer cells correlates with disease activity in multiple sclerosis patients. FASEB J. 19, 1902-1904. (Pubitemid 41598789)
17. Jahng A. W., Maricic I., Pedersen B., Burdin N., Naidenko O., Kronenberg M., Koezuka Y., and, Kumar V., (2001) Activation of natural killer T cells potentiates or prevents experimental autoimmune encephalomyelitis. J. Exp. Med. 194, 1789-1799. (Pubitemid 34028658)
18. Klink M., Cedzynski M., Swierzko A. St., Tchorzewski H., and, Sulowska Z., (2003) Involvement of nitric oxide donor compounds in the bactericidal activity of human neutrophils in vitro. J. Med. Microbiol. 52, 303-308. (Pubitemid 36515291)
19. Krishnamoorthy G., and, Wekerle H., (2009) EAE: an immunologist's magic eye. Eur. J. Immunol. 39, 2031-2035.
20. Levine S., and, Saltzman A., (1989) The hyperacute form of allergic encephalomyelitis produced in rats without the aid of pertussis vaccine. J. Neuropathol. Exp. Neurol. 48, 255-262. (Pubitemid 19116277)
21. Levine S., and, Sowinski R., (1975) Allergic encephalomyelitis in the reputedly resistant Brown Norway strain of rats. J. Immunol. 114, 597-601.
22. Levine S., and, Wenk E. J., (1965) A hyperacute form of allergic encephalomyelitis. Am. J. Pathol. 47, 61-88.
23. Levine S., Wenk E. J., Devlin H. B., Pieroni R. E., and, Levine L., (1966) Hyperacute allergic encephalomyelitis: adjuvant effect of pertussis vaccines and extracts. J. Immunol. 97, 363-368.
24. Liu J., Marino M. W., Wong G., Grail D., Dunn A., Bettadapura J., Slavin A. J., Old L., and, Bernard C. C., (1998) TNF is a potent anti-inflammatory cytokine in autoimmune-mediated demyelination. Nat. Med. 4, 78-83. (Pubitemid 28133083)
25. McCall T. B., Boughton-Smith N. K., Palmer R. M., Whittle B. J., and, Moncada S., (1989) Synthesis of nitric oxide from L-arginine by neutrophils. Release and interaction with superoxide anion. Biochem. J. 261, 293-296. (Pubitemid 19174794)
26. McColl S. R., Staykova M. A., Wozniak A., Fordham S., Bruce J., and, Willenborg D. O., (1998) Treatment with anti-granulocyte antibodies inhibits the effector phase of experimental autoimmune encephalomyelitis. J. Immunol. 161, 6421-6426. (Pubitemid 28536020)
27. Miljkovic D., Stosic-Grujicic S., Markovic M., Momcilovic M., Ramic Z., Maksimovic-Ivanic D., Mijatovic S., Popadic D., Cvetkovic I., and, Mostarica-Stojkovic M., (2006) Strain difference in susceptibility to experimental autoimmune encephalomyelitis between Albino Oxford and Dark Agouti rats correlates with disparity in production of IL-17, but not nitric oxide. J. Neurosci. Res. 84, 379-388. (Pubitemid 44126290)
28. Nozaki K., and, Abou-Fayssal N., (2010) High dose cyclophosphamide treatment in Marburg variant multiple sclerosis. A case report. J. Neurol. Sci. 296, 121-123.
29. O'Shea J. J., Ma A., and, Lipsky P., (2002) Cytokines and autoimmunity. Nat. Rev. Immunol. 2, 37-45. (Pubitemid 37328774)
30. Ransohoff R. M., (2006) EAE: pitfalls outweigh virtues of screening potential treatments for multiple sclerosis. Trends Immunol. 27, 167-168.
31. Salinthone S., Schillace R. V., Marracci G. H., Bourdette D. N., and, Carr D. W., (2008) Lipoic acid stimulates cAMP production via the EP2 and EP4 prostanoid receptors and inhibits IFN gamma synthesis and cellular cytotoxicity in NK cells. J. Neuroimmunol. 199, 46-55.
32. Sand K. L., Knudsen E., Rolin J., Al-Falahi Y., and, Maghazachi A. A., (2009) Modulation of natural killer cell cytotoxicity and cytokine release by the drug glatiramer acetate. Cell. Mol. Life Sci. 66, 1446-1456.
33. Sedgwick J., Brostoff S., and, Mason D., (1987) Experimental allergic encephalomyelitis in the absence of a classical delayed-type hypersensitivity reaction Severe paralytic disease correlates with the presence of interleukin 2 receptor-positive cells infiltrating the central nervous system. J. Exp. Med. 165, 1058-1075. (Pubitemid 17064505)
34. Segal B. M., (2007) The role of natural killer cells in curbing neuroinflammation. J. Neuroimmunol. 191, 2-7. (Pubitemid 350060993)
35. Shi F. D., Takeda K., Akira S., Sarvetnick N., and, Ljunggren H. G., (2000) IL-18 directs autoreactive T cells and promotes autodestruction in the central nervous system via induction of IFN-gamma by NK cells. J. Immunol. 165, 3099-3104.
36. Staykova M. A., Paridaen J. T., Cowden W. B., and, Willenborg D. O., (2005) Nitric oxide contributes to resistance of the Brown Norway rat to experimental autoimmune encephalomyelitis. Am. J. Pathol. 166, 147-157. (Pubitemid 40051668)
37. Stoll G., Jander S., and, Schroeter M., (2000) Cytokines in CNS disorders, neurotoxicity versus neuroprotection. J. Neural Transm. Suppl. 59, 81-89. (Pubitemid 30479409)
38. Stromnes I. M., Cerretti L. M., Liggitt D., Harris R. A., and, Goverman J. M., (2008) Differential regulation of central nervous system autoimmunity by T(H)1 and T(H)17 cells. Nat. Med. 14, 337-342. (Pubitemid 351347910)
39. Takahashi K., Miyake S., Kondo T., Terao K., Hatakenaka M., Hashimoto S., and, Yamamura T., (2001) Natural killer type 2 bias in remission of multiple sclerosis. J. Clin. Invest. 107, 23-29.
40. Wiendl H., and, Hohlfeld R., (2002) Therapeutic approaches in multiple sclerosis, lessons from failed and interrupted treatment trials. Bio. Drugs 16, 183-200. (Pubitemid 34852318)
41. Winkler-Pickett R., Young H. A., Cherry J. M., Diehl J., Wine J., Back T., Bere W. E., Mason A. T., and, Ortaldo J. R., (2008) In vivo regulation of experimental autoimmune encephalomyelitis by NK cells: alteration of primary adaptive responses. J. Immunol. 180, 4495-4506.
42. Wu F., Cao W., Yang Y., and, Liu A., (2010) Extensive infiltration of neutrophils in the acute phase of experimental autoimmune encephalomyelitis in C57BL/6 mice. Histochem. Cell Biol. 133, 313-322.
43. Young N. P., Weinshenker B. G., and, Lucchinetti C. F., (2008) Acute disseminated encephalomyelitis: current understanding and controversies. Semin. Neurol. 28, 84-94. (Pubitemid 351273086)